The term "estrogen dominance" gets used frequently in wellness spaces — but does it hold up scientifically? The short answer is no. Here's what the evidence actually says.


## How Estrogen Actually Works in the Menstrual Cycle


Estrogen levels in menstruating women naturally fluctuate throughout the menstrual cycle. During the luteal phase, estrogen levels are typically higher. A few days before menstruation, they begin to fall — and it's this drop, not the high levels themselves, that can trigger symptoms like headaches in some women. This is known as the **estrogen withdrawal hypothesis**.


The distinction matters: it's not the absolute level of estrogen that causes issues, but the *transition* from high to low. Recent research adds another layer of complexity — low estrogen in the early luteal phase may prime the brain to struggle with elevated progesterone levels later in the cycle, contributing to premenstrual mood symptoms.


## Why "Estrogen Dominance" Is a Misleading Term


"Estrogen dominance" lacks a clear scientific definition and is not evidence-based. The idea that higher estrogen relative to progesterone inherently causes symptoms or health issues is not supported by the research. What's often labeled as "estrogen dominance" is more accurately explained by **anovulatory cycles** — cycles in which ovulation does not occur.


In perimenopausal women, cycles may become erratic, and estrogen levels can appear moderate to high due to carryover from previous cycles. This alone doesn't necessarily cause symptoms. Vasomotor symptoms such as hot flashes tend to appear only when the frequency of ovulation drops below a certain threshold — and that threshold varies for each woman.


To put it plainly: **low estrogen, or more accurately, a shift to lower estrogen levels compared to an earlier point in the cycle or on average, is what's associated with PMS and perimenopause-related symptoms** — including mood changes, headaches, and migraines.


Elevated estrogen levels in the blood do not inherently impact a woman's health or cause symptoms. The focus should be on overall hormonal balance and cycle regularity — not on "estrogen dominance."


## "Estrogen Dominance," Breast Health, and Cancer Risk


The concept of "estrogen dominance" as a driver of breast cancer risk or poor breast health lacks scientific basis. A common error in interpreting research is assuming that a factor observed in people with a disease *caused* the disease — when it may be a consequence, or entirely unrelated.


A clear example: elevated estrogen levels in conditions like Polycystic Ovary Syndrome (PCOS) are a *result* of not ovulating, not the cause of the syndrome itself. [1]


The relationship between estrogen and breast cancer is also more nuanced than popular narratives suggest. Long-term studies — including the 20-year follow-up of the [Women's Health Initiative](https://www.nhlbi.nih.gov/science/womens-health-initiative-whi) — indicate that estrogen alone does not cause breast cancer, and that the effects of hormone therapy on breast health depend on multiple factors, including the specific type of hormone therapy used.


Oversimplified statements about hormones and cancer risk are not just inaccurate — they can be genuinely misleading. Evidence-based assessment of hormone therapy and breast health requires consideration of many factors, not a single concept like "estrogen dominance."



## Fibrocystic Breasts


It is not accurate to state that high estrogen causes fibrocystic breasts. In fact, research on fibrocystic breast changes and their relationship to estrogen levels is limited — this remains an understudied area.


## Breast Tenderness and Hormone Therapy


Breast tenderness can be caused by both the estrogen and progesterone components of hormone therapy. Notably, some women who experience breast tenderness *before* starting treatment actually see improvement after initiating hormone therapy — a finding that underscores the complexity of hormones and breast tissue response.


Hormone therapy, including estrogen, can increase breast density and may lead to breast pain in some women. However, this does not mean high estrogen alone causes fibrocystic breast changes. The relationship between hormones and breast tissue is multifactorial, and more targeted research is needed to draw definitive conclusions.


The science of women's hormones is nuanced — and the language we use should reflect that. Let's keep advancing women's health research and, in doing so, retire "estrogen dominance" from the conversation.